Definition spezifischer Proteinmuster für fortgeschrittene (metastasierte) Harnblasentumoren zur individuellen Prognosebestimmung und Therapiewahl
Klaus Junker(Klinikum Bremen-Mitte), Arndt Hartmann(Universitätsklinikum Erlangen), R. Pilchowski, Johannes Schubert(Fraunhofer Institute for Production Technology IPT), Ferdinand von Eggeling(Jena University Hospital), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 0
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258